Elongation factor 3D structures: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 154: | Line 154: | ||
**[[6s8z]] – EF – ''Corynebacterium glutamicum'' <br /> | **[[6s8z]] – EF – ''Corynebacterium glutamicum'' <br /> | ||
**[[5wxk]] – EF + EARP – ''Neisseria meningitidis''<br /> | **[[5wxk]] – EF + EARP – ''Neisseria meningitidis''<br /> | ||
*EF-Ts | *EF-Ts | ||
| Line 226: | Line 225: | ||
**[[6gmh]], [[6gml]] – hEF-Spt4 + EF-Spt5 + EF-Spt6 in transcription complex – Cryo EM<br /> | **[[6gmh]], [[6gml]] – hEF-Spt4 + EF-Spt5 + EF-Spt6 in transcription complex – Cryo EM<br /> | ||
**[[5oik]] – bEF-Spt4 + EF-Spt5 + RNA polymerase II <br /> | **[[5oik]] – bEF-Spt4 + EF-Spt5 + RNA polymerase II <br /> | ||
**[[7nky]] – yEF-Spt4 + EF-Spt5 + EF-Spt16 in RNA polymerase II elongation complex - CryoEM<br /> | |||
**[[2exu]] – yEF-Spt4 residues 1-99 + EF-Spt5 residues 285-375<br /> | **[[2exu]] – yEF-Spt4 residues 1-99 + EF-Spt5 residues 285-375<br /> | ||
**[[4zn3]], [[4zn1]] – EF-Spt4 + EF-Spt5 – ''Methanocaldococcus jannaschii'' <br /> | **[[4zn3]], [[4zn1]] – EF-Spt4 + EF-Spt5 – ''Methanocaldococcus jannaschii'' <br /> | ||
| Line 249: | Line 249: | ||
**[[4z2m]] – hEF middle domain + histone H3.1 + histone H4<br /> | **[[4z2m]] – hEF middle domain + histone H3.1 + histone H4<br /> | ||
**[[6gme]] – hEF SH2 domain residues 1317-1334<br /> | **[[6gme]] – hEF SH2 domain residues 1317-1334<br /> | ||
**[[6ted]] – pEF in RNA polymerase II transcription complex - CryoEM<br /> | |||
**[[3psf]], [[3psi]] – yEF core domain residues 235-1259<BR /> | **[[3psf]], [[3psi]] – yEF core domain residues 235-1259<BR /> | ||
**[[3psj]], [[3psk]] – yEF SH2 domain residues 1247-1451<BR /> | **[[3psj]], [[3psk]] – yEF SH2 domain residues 1247-1451<BR /> | ||
| Line 288: | Line 289: | ||
*Elongin BC complex | *Elongin BC complex | ||
**[[1lqb]], [[1lm8]] – hEloBC + | **[[1lqb]], [[1lm8]] – hEloBC + VHL + hypoxia inducible factor 1 α<br /> | ||
**[[6i7q]], [[6i7r]] – hEloBC + | **[[6i7q]], [[6i7r]] – hEloBC + VHL + hypoxia inducible factor 2 α<br /> | ||
**[[3zrc]], [[3ztc]], [[3ztd]], [[3zun]], [[6fmi]], [[6fmj]], [[6fmk]], [[5nw2]], [[5nw1]], [[5nw0]], [[5nvz]], [[5nvy]], [[5nvx]], [[5nvw]], [[5nvv]], [[4w9l]], [[4w9k]], [[4w9j]], [[4w9i]], [[4w9h]], [[4w9g]], [[4w9f]], [[4w9e]], [[4w9d]], [[4w9c]], [[6gfy]] - hEloBC + | **[[3zrc]], [[3ztc]], [[3ztd]], [[3zun]], [[6fmi]], [[6fmj]], [[6fmk]], [[5nw2]], [[5nw1]], [[5nw0]], [[5nvz]], [[5nvy]], [[5nvx]], [[5nvw]], [[5nvv]], [[4w9l]], [[4w9k]], [[4w9j]], [[4w9i]], [[4w9h]], [[4w9g]], [[4w9f]], [[4w9e]], [[4w9d]], [[4w9c]], [[6gfy]] - hEloBC + VHL + inhibitor<br /> | ||
**[[5t35]], [[6sis]] - hEloBC + | **[[5t35]], [[6sis]] - hEloBC + VHL + BRD4<br /> | ||
**[[4wqo]] - hEloBC + | **[[7khh]] - hEloBC + VHL + BRD4 + inhibitor<br /> | ||
**[[6hr2]], [[6hay]], [[6hax]] - hEloBC + | **[[4wqo]] - hEloBC + VHL + cullin-2 <br /> | ||
**[[6gmr]], [[6gfx]], [[6bvb]] - hEloBC + | **[[6hr2]], [[6hay]], [[6hax]] - hEloBC + VHL + transcription activator <br /> | ||
**[[6gmr]], [[6gfx]], [[6bvb]] - hEloBC + VHL + hypoxia inducible factor peptide <br /> | |||
**[[5n4w]] - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2 + RBX1<br /> | **[[5n4w]] - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2 + RBX1<br /> | ||
**[[3zrf]], [[5lli]], [[6gmx]], [[6gmq]], [[6gmn]], [[6gfz]] - hEloBC + | **[[3zrf]], [[5lli]], [[6gmx]], [[6gmq]], [[6gmn]], [[6gfz]] - hEloBC + VHL<br /> | ||
**[[6zhc]] - hEloBC + VHL + Bcl-2-like protein<br /> | |||
**[[2c9w]], [[2izv]], [[2jz3]], [[5bo4]] – hEloBC + suppressor of cytokine signaling<br /> | **[[2c9w]], [[2izv]], [[2jz3]], [[5bo4]] – hEloBC + suppressor of cytokine signaling<br /> | ||
**[[6c5x]] – hEloBC + suppressor of cytokine signaling + Gp130 peptide<br /> | **[[6c5x]] – hEloBC + suppressor of cytokine signaling + Gp130 peptide<br /> | ||
| Line 305: | Line 308: | ||
**[[1vcb]] – hEloBC + VHL<br /> | **[[1vcb]] – hEloBC + VHL<br /> | ||
**[[6v9h]] – hEloBC + creatine kinase + ASB-9 – Cryo EM<br /> | **[[6v9h]] – hEloBC + creatine kinase + ASB-9 – Cryo EM<br /> | ||
**[[6r6h]], [[6r7f]], [[6r7h]], [[6r7i]], [[6r7n]] – hEloBC in signalosome – Cryo EM<br /> | |||
**[[2fnj]] - mEloBC + GUSTAVUS | **[[2fnj]] - mEloBC + GUSTAVUS | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:15, 13 July 2021
3D structures of elongation factor
Updated on 13-July-2021
- 4hfx – hEloA F-box domain
- 4hfx – hEloA F-box domain
- Elongin C
- Elongin BC complex
- 1lqb, 1lm8 – hEloBC + VHL + hypoxia inducible factor 1 α
- 6i7q, 6i7r – hEloBC + VHL + hypoxia inducible factor 2 α
- 3zrc, 3ztc, 3ztd, 3zun, 6fmi, 6fmj, 6fmk, 5nw2, 5nw1, 5nw0, 5nvz, 5nvy, 5nvx, 5nvw, 5nvv, 4w9l, 4w9k, 4w9j, 4w9i, 4w9h, 4w9g, 4w9f, 4w9e, 4w9d, 4w9c, 6gfy - hEloBC + VHL + inhibitor
- 5t35, 6sis - hEloBC + VHL + BRD4
- 7khh - hEloBC + VHL + BRD4 + inhibitor
- 4wqo - hEloBC + VHL + cullin-2
- 6hr2, 6hay, 6hax - hEloBC + VHL + transcription activator
- 6gmr, 6gfx, 6bvb - hEloBC + VHL + hypoxia inducible factor peptide
- 5n4w - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2 + RBX1
- 3zrf, 5lli, 6gmx, 6gmq, 6gmn, 6gfz - hEloBC + VHL
- 6zhc - hEloBC + VHL + Bcl-2-like protein
- 2c9w, 2izv, 2jz3, 5bo4 – hEloBC + suppressor of cytokine signaling
- 6c5x – hEloBC + suppressor of cytokine signaling + Gp130 peptide
- 6i5n, 6i5j – hEloBC + suppressor of cytokine signaling + growth hormone receptor peptide
- 6i4x – hEloBC + suppressor of cytokine signaling + erythropoietin peptide
- 6p59 - hEloBC + virion infectivity factor + CBF b
- 3zkj - hEloBC + ankyrin rep
- 1vcb – hEloBC + VHL
- 6v9h – hEloBC + creatine kinase + ASB-9 – Cryo EM
- 6r6h, 6r7f, 6r7h, 6r7i, 6r7n – hEloBC in signalosome – Cryo EM
- 2fnj - mEloBC + GUSTAVUS
- 1lqb, 1lm8 – hEloBC + VHL + hypoxia inducible factor 1 α